GPN-600X120-EdgePro
As imaging technologies continue to develop, OCT brings us anterior segment applications. On the forefront is anterior segment OCT of the epithelial layer of the cornea. Optovue (FREMONT, CA) obtained U.S. Food and Drug Administration (FDA) approval for its epithelial...
Some of the more common things I hear when talking with colleagues about referrals to ophthalmology are these: I have a great relationship with Dr. OMD. They send me letters back and they send the patient back for post-op care. My OMD is...
If I’m being honest, I almost always cringe when I see our pediatric surgeon calling my cell phone. He’s the nicest guy in the world. However, it typically means he’s sending someone my way. Odds are it’s almost always...
I am a bit of an over-achiever. I want all my patients to have perfect outcomes, and I don’t like surprises. When I send a patient for surgery, I make a note in my referral letter as to what the...
Over the past few years, there seems to be an explosion of attention given to meibomian gland dysfunction/disease (MGD). First described by Dr. Donald Korb and associates (what’s new? He has brought us GPC, lid wiper epitheliopathy, and a...
Amniotic membranes have become a popular choice among practitioners for corneal related issues. These stem cell contact lenses can be used for dry eye, corneal abrasions, recurrent corneal erosions, corneal ulcers, filamentary keratitis, corneal ulcers, chemical burns, and more!...
Keratoconus prevalence: Much more common than previously thought Previously, the frequency of keratoconus was most commonly reported to be 1 in 2,000, a value based on a registration study in Olmsted County, Minnesota, conducted 1935-1982; the study reported a prevalence...
Babyboomers are aging, and they have high expectations for their vision. They want to see everything and are more willing to pay for it. As premium surgeries continue to increase and expectations continue to be set high, we need...
Diagnose Early, Stop Progression, Rehabilitate Vision The new mantra of keratoconic care is: Diagnose early, Stop progression, Rehabilitate vision. Currently, in the stop progression category, there is only 1 FDA approved treatment to stop progression of keratoconus, corneal crosslinking (CXL)....
Corneal collagen cross-linking (CXL) has increasingly become the hot topic of nearly every conversation amongst corneal experts around the globe. When effective, the procedure provides the best opportunity for arresting or slowing the ectatic progression of the irregular cornea....

Send this to a friend